| 150 mg/day(n = 195) | 600 mg/day(n = 198) | 900 mg/day(n = 193) | p Value | |
| Gender | ||||
| Male | 97 (49.7%) | 117 (59.1%) | 123 (63.7%) | 0.018 |
| Female | 98 (50.3%) | 81 (40.9%) | 70 (36.3%) | |
| Age (years) | 58.0±12.2 | 57.7±12.0 | 59.8±10.1 | 0.152 |
| Height (cm) | 160.1±9.5 | 161.9±9.2 | 160.8±8.7 | 0.163 |
| Weight (kg) | 58.8±11.4 | 61.8±11.2 | 61.6±11.9 | 0.017 |
| ALT (IU/l) | 109.2±49.7 | 106.3±59.4 | 110.6±57.3 | 0.745 |
| AST (IU/l) | 84.0±39.1 | 82.4±41.8 | 85.2±45.0 | 0.796 |
| GGT (IU/l) | 87.5±73.0 | 82.4±62.2 | 85.9±66.3 | 0.744 |
| Interferon* | ||||
| Absent | 119 (61.0%) | 100 (50.5%) | 96 (49.7%) | 0.044 |
| Present | 76 (39.0%) | 98 (49.5%) | 97 (50.3%) | |
Data represent the number of patients or mean±SD.
*Previous interferon treatment.